Showing 41-50 of 60 results for "".
Controversies in Mohs Surgery
https://practicaldermatology.com/topics/skin-cancer-photoprotection/controversies-in-mohs-surgery/19129/Joel Schlessinger, MD discusses the changing landscape of Mohs surgery for skin cancer. Specifically he addresses turf wars among professional organizations.Skincare 2023: Year in Review
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/skincare-2023-year-in-review/24011/Practical Dermatology Co-Chief Medical Editor Joel Schlessinger, MD, shares his favorite skincare products of 2023 – and a few other insights, as well.- Happy 10th Birthday Dysport!https://practicaldermatology.com/news/happy-10th-birthday-dysport/2460015/Galderma Laboratories’ Dysport (abobotulinumtoxinA) is ringing in its 10th birthday. To celebrate this milestone, Galderma is offering double points for Dysport aesthetic treatments registered in the ASPIRE Rewards program through July 31, 2019, which patients can redeem for discounts on their nex…
Consolidation or Competition: The Road to Optimization
https://practicaldermatology.com/topics/practice-management/consolidation-or-competition-the-road-to-optimization/18769/What's next for the dermatology/aesthetics industry? Joel Schlessinger, MD, founder of Cosmetic Surgery Forum, describes what has taken place in the aesthetic space and predicts what's next, especially in the laser/device space.Mohs Certification: Finding a Middle Ground
https://practicaldermatology.com/topics/practice-management/mohs-certification-finding-a-middle-ground/18681/Can specialists reach a consensus on Mohs certification? Joel Schlessinger, MD, FAAD certainly hopes so. He spoke with DermTube.com about the controversy over certification for the surgical technique to treat skin cancer and urged compromise.Family Affair
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/family-affair/19697/Fun, fresh, and scientific. That's how host Joel Cohen, MD describes CSF—now in its 11th year. Meeting founder Joel Schlessinger, MD weighs in on his vision for the meeting and what he learned this year.Topical Toxins: Now and Later
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/topical-toxins-now-and-later/18768/Topical neurotoxins are in late-stage development, with the potential to offer "softer" results and reduction of fine wrinkles. But they may not be approved for another few years. In the meantime, micro channel delivery of toxins, such as with AquaGold, is an option. Joel Schlessinger, MD, founder oBuying a Laser, Circa 2024
https://practicaldermatology.com/issues/april-2024/buying-a-laser-circa-2024/24439/Joel Schlessinger, MD, shares his experiences with the process of adding new equipment to his dermatology practice, culminating in the purchase of the Sciton mJoule and JouleX lasers. He also highlights the importance of planning early for tax deductions and emphasizes the value of a supportive netwCSF 2022 Highlights
https://practicaldermatology.com/conferences/cosmetic-surgery-forum-2022/csf-2022-highlights/20162/Joel Schlessinger, MD says the 2022 Cosmetic Surgery Forum was a success. The unique format of the meeting encourages presenters and audience members to interact and engage in lively discussions that allow attendees to leave the meeting with ideas they can use in their practices immediately.Make Your Mark: Formulate a Product Line
https://practicaldermatology.com/topics/practice-management/make-your-mark-formulate-a-product-line/20023/Dispensing skincare offers benefits to your practice and your patients. Joel Schlessinger, MD discusses his journey with his son to developing their own product formulation and offers insights and encourages colleagues to use their unique talents to do the same.